The bone marrow microenvironment–Home of the leukemic blasts

MS Shafat, B Gnaneswaran, KM Bowles… - Blood reviews, 2017 - Elsevier
Abstract Acute Myeloid Leukaemia (AML) is a genetically, biologically and clinically
heterogeneous set of diseases, which are characterised by an increased growth of …

[HTML][HTML] Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications

L Arranz, M del Mar Arriero, A Villatoro - Blood reviews, 2017 - Elsevier
Abstract Interleukin-1β (IL-1β) is a pleiotropic cytokine that exerts multiple roles in both
physiological and pathological conditions. It is produced by different cell subsets, and drives …

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia …

M Azadniv, JR Myers, HR McMurray, N Guo, P Rock… - Leukemia, 2020 - nature.com
Bone marrow mesenchymal stromal cells (MSCs) constitute one of the important
components of the hematopoietic microenvironmental niche. In vivo studies have shown that …

Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients

EK Von der Heide, M Neumann, S Vosberg, AR James… - Leukemia, 2017 - nature.com
The contribution of molecular alterations in bone marrow mesenchymal stromal cells (BM-
MSC) to the pathogenesis of acute myeloid leukemia (AML) is poorly understood. Thus we …

[HTML][HTML] Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner

YS Al-Matary, L Botezatu, B Opalka, JM Hönes… - …, 2016 - ncbi.nlm.nih.gov
The growth of malignant cells is not only driven by cell-intrinsic factors, but also by the
surrounding stroma. Monocytes/Macrophages play an important role in the onset and …

[HTML][HTML] The role of microenvironment and immunity in drug response in leukemia

E Bakker, M Qattan, L Mutti, C Demonacos… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Leukemia is a cancer of the white blood cells, with over 54,000 new cases per year
diagnosed worldwide and a 5-year survival rate below 60%. This highlights a need for …

Targeting FLT3 to treat leukemia

H Konig, M Levis - Expert opinion on therapeutic targets, 2015 - Taylor & Francis
Introduction: Approximately 23% of acute myeloid leukemia (AML) patients younger than 60
years of age carry a mutation in the transmembrane domain of the FMS-like tyrosine kinase …

CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway

J Cheng, Y Li, S Liu, Y Jiang, J Ma, L Wan… - The FASEB …, 2019 - Wiley Online Library
The role of proinflammatory cytokines secreted by the bone marrow mesenchymal stromal
cells (BM‐MSCs) in the progression of acute myeloid leukemia (AML) is poorly understood …

The roles of mesenchymal stromal/stem cells in tumor microenvironment associated with inflammation

D Trivanović, J Krstić, IO Djordjević… - Mediators of …, 2016 - Wiley Online Library
State of tumor microenvironment (TME) is closely linked to regulation of tumor growth and
progression affecting the final outcome, refractoriness, and relapse of disease. Interactions …

The positive effects of Ginsenoside Rg1 upon the hematopoietic microenvironment in a D-Galactose-induced aged rat model

W Hu, P Jing, L Wang, Y Zhang, J Yong… - BMC complementary and …, 2015 - Springer
Abstract Background Ginsenoside Rg1 (Rg1) is one of the most active ingredients in Panax
ginseng and has been proven to have anti-oxidative and anti-aging properties. However …